Neoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck Cancer
Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness and safety of neoadjuvant
chemotherapy (chemotherapy given before radiotherapy) using cisplatin and docetaxel, followed
by carboplatin given at the same time as radiotherapy in the treatment of locally advanced
head and neck cancer.